Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial | |
Li, Ning7; Zhang, Youzhong8; Wang, Jing9; Zhu, Jianqing10; Wang, Li11; Wu, Xiaohua12; Yao, Desheng13; Wu, Qiang14; Liu, Jihong15; Tang, Junying16 | |
刊名 | GYNECOLOGIC ONCOLOGY |
2021-08-01 | |
卷号 | 162 |
ISSN号 | 0090-8258 |
WOS研究方向 | Oncology ; Obstetrics & Gynecology |
语种 | 英语 |
出版者 | ACADEMIC PRESS INC ELSEVIER SCIENCE |
WOS记录号 | WOS:000687070800098 |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/125046] |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Zhejiang Univ, Sch Med, Womans Hosp, Hangzhou, Peoples R China 2.Beijing Canc Hosp, Beijing, Peoples R China 3.Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China 4.Tianjin Cent Hosp Gynecol Obstet, Tianjin, Peoples R China 5.Liaoning Canc Hosp & Insititute, Shenyang, Liaoning, Peoples R China 6.Jiangsu Hengrui Med Co Ltd, Shanghai, Peoples R China 7.Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China 8.Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China 9.Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China 10.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Beijing, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Ning,Zhang, Youzhong,Wang, Jing,et al. Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial[J]. GYNECOLOGIC ONCOLOGY,2021,162. |
APA | Li, Ning.,Zhang, Youzhong.,Wang, Jing.,Zhu, Jianqing.,Wang, Li.,...&Wu, Lingying.(2021).Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial.GYNECOLOGIC ONCOLOGY,162. |
MLA | Li, Ning,et al."Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial".GYNECOLOGIC ONCOLOGY 162(2021). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论